Beijing Anzhen Hospital, Capital Medical University

Beijing, Beijing Municipality 100029

1 studies enrolling now · 9 studies all time

What they study most

Acute Myocardial Infarction (AMI), Cardiovascular Risk, Chronic Kidney Disease, Chronic Kidney Diseases, Heart Failure, Hemorrhage, Inflammation, Invasive Procedure, Primary Membranous Nephropathy, Type 2 Diabetes Mellitus, Urgent Surgery

Studies at this site

• ARTEMIS - A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With a Heart Attack — Recruiting now
• ZEUS - A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With Cardiovascular Disease, Chronic Kidney Disease and Inflammation — Completed
• A Study to Examine the Efficacy and Safety of Zanubrutinib Given to Adults With Primary Membranous Nephropathy — Running, not enrolling
• A Study of Tirzepatide (LY3298176) Compared With Dulaglutide on Major Cardiovascular Events in Participants With Type 2 Diabetes — Completed
• A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With Heart Failure and Inflammation — Running, not enrolling
• Efficacy and Safety of Volenrelaxin in Adults With Chronic Kidney Disease — Withdrawn before enrolling
• Efficacy and Safety of KBP-5074 in Uncontrolled Hypertension and Moderate or Severe Chronic Kidney Disease (CKD) — Stopped early
• Levels of Inflammation in People With Cardiovascular Disease (POSEIDON) — Completed
• Bentracimab in Ticagrelor-treated Patients With Uncontrolled Bleeding or Requiring Urgent Surgery or Invasive Procedure — Completed